Clinical Trial Update: A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

View source ↗

Summary

This real-world clinical trial update reports on long-term adherence and persistence to inclisiran, evolocumab, and alirocumab among patients with cardiovascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Disease
• Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• LEQVIO (inclisiran)
• Praluent (alirocumab)
• Repatha (Evolocumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease | Status: NOT_YET_RECRUITING